Rare diseases
Investigational molecules
Locations
Immune Modulation Study of Rilvegostomig and Pembrolizumab in Patients with Advanced Gastric Cancer
SpainPhase 1/2 Study of Oral TRI-611 in Adults With Advanced ALK‑Positive Non‑Small Cell Lung Cancer
FranceColchicine for Reducing Dependency and Vascular Events in Patients After Acute Intracerebral Hemorrhage
BelgiumPhase 2 Randomized Study of Mivelsiran in Adults with Early-Stage Down Syndrome-Associated Alzheimer’s Disease
GermanyCapecitabine drug combination in perioperative treatment for patients with gastric and esophageal cancer
The NetherlandsEffectiveness and Safety of INTESTIFIX in Removing Vancomycin‑Resistant Enterococci Colonization in Immunocompromised Patients – drug combination
GermanyA Phase 3 Study of Delgocitinib Cream to Evaluate Efficacy and Safety in Adult Women with Lichen Sclerosus
FrancePhase 1/2 First‑in‑Human Study of Oral GSK5471713B in Adults with Metastatic Castration‑Resistant Prostate Cancer
FranceEvaluation of belantamab mafodotin plus drug combination in adult patients with newly diagnosed light chain amyloidosis
GreeceSafety, Dose‑Finding and Feasibility Study of CD30/CEA CART in Patients with Liver Metastases from CEA‑Positive Colorectal Cancer
GermanySafety and Tolerability of PTI5803 in Patients Aged 14 Years and Older With Drug‑Resistant Seizures Due to Focal Cortical Dysplasia
FranceStudy of pirtobrutinib plus epcoritamab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
